HSGX - Histogenics Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Histogenics Corporation

830 Winter Street
3rd Floor
Waltham, MA 02451
United States
781-547-7900
http://www.histogenics.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees49

Key Executives

NameTitlePayExercisedYear Born
Mr. Adam D. GridleyPres, Treasurer, Sec., Consultant & Director817.73kN/A1972
Mr. Jonathan I. LieberInterim Chief Financial Officer503.69kN/A1970
Mr. Stephen R. KennedyConsultant593.35kN/A1957
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Histogenics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.